Fingerprint
Dive into the research topics where Emmanuel Petricoin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Developing an algorithm for Molecular Tailored Therapy
Brody, J. J., Petricoin, E., Albanese, C., Madhavan, S. & Pishvaian, M. M.
Pancreatic Cancer Action Network, American Association for Cancer Research
1/01/15 → …
Project: Research
-
Developing an algorithm for Molecular Tailored Therapy
Brody, J. J., Petricoin, E., Pishvaian, M. M., Albanese, C. & Madhavan, S.
Pancreatic Cancer Action Network, American Association for Cancer Research
1/07/15 → 30/06/18
Project: Research
-
CGE25-106: MHC II More Effectively Predicts Response to Pembrolizumab Than PD-L1 in HER2 Negative Patients
Fogarty, E., Corgiat, B., Sparks, K., Arnell, C., Petricoin, E., Davis, J. & Mueller, C., 28 Mar 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 35Research output: Contribution to journal › Article › peer-review
-
Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database
Levi, A., Blais, E., Davelaar, J., Ebia, M. I., Minasyan, A., Nikravesh, N., Gresham, G., Zheng, L., Chuy, J. W., Shroff, R. T., Wadlow, R. C., DeArbeloa, P., Matrisian, L. M. C., Petricoin, E., Pishvaian, M. J., Gong, J., Hendifar, A. E. & Osipov, A., 1 Mar 2025, In: Oncologist. 30, 3, oyaf007.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
Drizyte-Miller, K., Engstrom, L. D., Klomp, J. A., Stalnecker, C. A., Stamey, A. G., Taylor, K. E., Roach, M. K., Robb, R., Waters, L. M., Calinisan, A., Degan, S., Chang, W. H., Helu, X. M., Nguyen, D., Baldelli, E., Pierobon, M., Petricoin, E. F., Briere, D. M., Hallin, J., Christensen, J. G., & 4 others, 15 Sep 2025, In: Cancer Research. 85, 18, p. 3540-3557 18 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer
DeLiberty, J. M., Roach, M. K., Stalnecker, C. A., Robb, R., Schechter, E. G., Pieper, N. L., Taylor, K. E., Pita, L. M., Yang, R., Bang, S., Drizyte-Miller, K., Ackermann, S. E., Nicewarner Peña, S. R., Baldelli, E., Min, S. M., Drewry, D. H., Petricoin, E. F., Morris, J. P., Der, C. J., Cox, A. D., & 1 others, 15 Apr 2025, In: Cancer Research. 85, 8, p. 1479-1495 17 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Defining the MYC-regulated transcriptome and kinome that support KRAS-and ERK-dependent growth of pancreatic cancer
Hibshman, P. S., Stalnecker, C. A., Klomp, J. A., Drizyte-Miller, K., Klomp, J. E., Cole Edwards, A., Pita, L. M., Hodge, R. G., Nathaniel Diehl, J., Mouery, R. D., Mouery, B. L., Snare, K. R., Waters, A. M., Peng, S., Barker, N. K., Pierobon, M., Rashid, N. U., Tran, N. L., Herring, L. A., Graves, L. M., & 4 others, 30 Sep 2025, In: Science Signaling. 18, 906, eadu7145.Research output: Contribution to journal › Article › peer-review
Press/Media
-
-
-
Method of Determining Risk for Skin Cancer Development and Skin Cancer Therapeutic Prevention by Measuring PD-1/PD-L1 Signaling Pathway Members
6/01/26
1 item of Media coverage
Press/Media